NCT06367478

Brief Summary

the investigators study different modality to obtain nerve evoked reponses. They use different parameters of acquisition and stimulation and they compare amplitude and latency of nerve conduction response

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
125

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 22, 2021

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 16, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 22, 2024

Completed
Last Updated

April 16, 2024

Status Verified

March 1, 2024

Enrollment Period

3 months

First QC Date

March 29, 2024

Last Update Submit

April 11, 2024

Conditions

Nerve ConditionHealth, Subjective

Outcome Measures

Primary Outcomes (1)

  • best amplitude of nerve conduction study

    baseline and after 30 minutes

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

healthy subjects

You may qualify if:

  • absence of previous nervous pathologies

You may not qualify if:

  • nerve disease
  • diabetes
  • polyneuropathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico of Milan

Milan, 20122, Italy

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2024

First Posted

April 16, 2024

Study Start

August 1, 2021

Primary Completion

October 22, 2021

Study Completion

October 22, 2024

Last Updated

April 16, 2024

Record last verified: 2024-03

Locations

IT(1)